Adial Pharmaceuticals

ADIL NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-09-30 2023-06-30 2023-03-31
Revenue $32 $0 $0 $0
Gross Profit 32 -15
EBITDA -1,783 -1,357 -1,477 -2,890
EBIT -1,783 -1,357 -1,461 -2,920
Net Income -1,920 -1,384 1,087 -2,890
Net Change In Cash 32 0 0 0
Free Cash Flow -1,222 -1,390 -1,894 -2,298
Cash 2,827 315 1,218 2,312
Basic Shares 1,663 1,178 1,131 1,058

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -60 -55
EBITDA -6,887 -13,778 -15,855 -10,927
EBIT -6,887 -13,317 -19,288 -10,927
Net Income -7,748 -12,731 -19,423 -10,860
Net Change In Cash 0 0 0 0
Cost of Revenue -2,375
Free Cash Flow -6,806 -11,185 -12,014 -7,633
Cash 2,827 4,001 6,062 4,401
Basic Shares 1,424 40 743 498

Earnings Calls

Quarter EPS
2024-03-31 -$0.62
2023-12-31 -$1.35
2023-09-30 -$1.18
2023-06-30 $0.96